{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:21:00Z","timestamp":1774930860952,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":650,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NNSF: 81171270; 30800367; 30770776"],"award-info":[{"award-number":["NNSF: 81171270; 30800367; 30770776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Perspect Psychiatr Care"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1111\/ppc.12050","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T03:49:53Z","timestamp":1385005793000},"page":"257-263","source":"Crossref","is-referenced-by-count":13,"title":["Frequency of Hyperprolactinemia and Its Associations With Demographic and Clinical Characteristics and Antipsychotic Medications in Psychiatric Inpatients in China"],"prefix":"10.1155","volume":"50","author":[{"given":"Zhi-Min","family":"Wang","sequence":"first","affiliation":[{"name":"Beijing Anding Hospital; Capital Medical University; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tao","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Chinese University of Hong Kong; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Rong","family":"An","sequence":"additional","affiliation":[{"name":"Beijing Anding Hospital; Capital Medical University; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[{"name":"Division of Psychiatry Research; The Zucker Hillside Hospital; North Shore-Long Island Jewish Health System; Glen Oaks New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor S.","family":"Ungvari","sequence":"additional","affiliation":[{"name":"School of Psychiatry and Clinical Neurosciences; University of Western Australia; Perth Australia"},{"name":"The University of Notre Dame Australia\/Marian Centre; Perth Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Anding Hospital; Capital Medical University; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly Y. C.","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Chinese University of Hong Kong; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Jing","family":"Bo","sequence":"additional","affiliation":[{"name":"Beijing Anding Hospital; Capital Medical University; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Chinese University of Hong Kong; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Liang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Chinese University of Hong Kong; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen F. K.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Chinese University of Hong Kong; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"key":"10.1111\/ppc.12050-BIB0001|ppc12050-cit-0001","volume-title":"Practice guideline for the treatment of patients with schizophrenia","author":"American Psychiatric Association","year":"1997"},{"issue":"7","key":"10.1111\/ppc.12050-BIB0002|ppc12050-cit-0002","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","article-title":"Hyperprolactinaemia in early psychosis-not only due to antipsychotics","volume":"34","author":"Aston","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"6","key":"10.1111\/ppc.12050-BIB0003|ppc12050-cit-0003","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","article-title":"Dopamine as a prolactin (PRL) inhibitor","volume":"22","author":"Ben-Jonathan","year":"2001","journal-title":"Endocrine Reviews"},{"issue":"7","key":"10.1111\/ppc.12050-BIB0004|ppc12050-cit-0004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0269881107078281","article-title":"Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics","volume":"21","author":"Bushe","year":"2007","journal-title":"Journal of Psychopharmacology"},{"issue":"2 Suppl.","key":"10.1111\/ppc.12050-BIB0005|ppc12050-cit-0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","article-title":"A review of the association between antipsychotic use and hyperprolactinaemia","volume":"22","author":"Bushe","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"1-3","key":"10.1111\/ppc.12050-BIB0006|ppc12050-cit-0006","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.schres.2009.07.012","article-title":"Schizophrenia and breast cancer incidence: A systematic review of clinical studies","volume":"114","author":"Bushe","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"6","key":"10.1111\/ppc.12050-BIB0007|ppc12050-cit-0007","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/jcp.0b013e31815ac4e5","article-title":"Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: Recent developments and current perspectives","volume":"27","author":"Byerly","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2-3","key":"10.1111\/ppc.12050-BIB0008|ppc12050-cit-0008","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2008.09.019","article-title":"Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study","volume":"107","author":"Byerly","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1111\/ppc.12050-BIB0009|ppc12050-cit-0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1758-5872.2010.00068.x","article-title":"Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: Comparison of REAP-2001 and REAP-2004 studies","volume":"2","author":"Chong","year":"2010","journal-title":"Asia-Pacific Psychiatry"},{"issue":"Suppl. 2","key":"10.1111\/ppc.12050-BIB0010|ppc12050-cit-0010","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: Individualising the selection, dosing, and switching of antipsychotics","volume":"25","author":"Correll","year":"2010","journal-title":"European Psychiatry"},{"issue":"7","key":"10.1111\/ppc.12050-BIB0011|ppc12050-cit-0011","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2 Suppl.","key":"10.1111\/ppc.12050-BIB0012|ppc12050-cit-0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269216307087148","article-title":"Prolactin and dopamine: What is the connection? A review article","volume":"22","author":"Fitzgerald","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1111\/ppc.12050-BIB0013|ppc12050-cit-0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2012.03.018","article-title":"Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009","volume":"138","author":"Gallego","year":"2012","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1111\/ppc.12050-BIB0014|ppc12050-cit-0014","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14740338.2012.683523","article-title":"Safety and tolerability of antipsychotic polypharmacy","volume":"11","author":"Gallego","year":"2012","journal-title":"Expert Opinion on Drug Safety"},{"issue":"20","key":"10.1111\/ppc.12050-BIB0015|ppc12050-cit-0015","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"issue":"2","key":"10.1111\/ppc.12050-BIB0016|ppc12050-cit-0016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.2010.03814.x","article-title":"Antipsychotics and hyperprolactinaemia: Mechanisms, consequences and management","volume":"74","author":"Holt","year":"2011","journal-title":"Clinical Endocrinology"},{"issue":"10","key":"10.1111\/ppc.12050-BIB0017|ppc12050-cit-0017","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/00048674.2011.589044","article-title":"Antipsychotic-induced hyperprolactinaemia","volume":"45","author":"Inder","year":"2011","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1111\/ppc.12050-BIB0018|ppc12050-cit-0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy","volume":"8","author":"Kane","year":"1998","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1111\/ppc.12050-BIB0019|ppc12050-cit-0019","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v68n0206","article-title":"Aripiprazole for treatment-resistant schizophrenia: Results of a multicenter, randomized, double-blind, comparison study versus perphenazine","volume":"68","author":"Kane","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1111\/ppc.12050-BIB0020|ppc12050-cit-0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: A pharmacological analysis in rats","volume":"302","author":"Kapur","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1111\/ppc.12050-BIB0021|ppc12050-cit-0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/YCO.0b013e328355e1ac","article-title":"Osteoporosis and fracture risk in people with schizophrenia","volume":"25","author":"Kishimoto","year":"2012","journal-title":"Current Opinion in Psychiatry"},{"issue":"1","key":"10.1111\/ppc.12050-BIB0022|ppc12050-cit-0022","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488406775268255","article-title":"Improving adherence to antipsychotic pharmacotherapy","volume":"1","author":"Masand","year":"2006","journal-title":"Current Clinical Pharmacology"},{"issue":"6","key":"10.1111\/ppc.12050-BIB0023|ppc12050-cit-0023","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4088\/JCP.v66n0614","article-title":"Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients","volume":"66","author":"Melkersson","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"8","key":"10.1111\/ppc.12050-BIB0024|ppc12050-cit-0024","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4065\/80.8.1050","article-title":"Medication-induced hyperprolactinemia","volume":"80","author":"Molitch","year":"2005","journal-title":"Mayo Clinic Proceedings"},{"issue":"11","key":"10.1111\/ppc.12050-BIB0025|ppc12050-cit-0025","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4088\/JCP.v65n1108","article-title":"Prevalence of hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment","volume":"65","author":"Montgomery","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2 Suppl.","key":"10.1111\/ppc.12050-BIB0026|ppc12050-cit-0026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0269881107087346","article-title":"Antipsychotics and hyperprolactinaemia: Clinical recommendations","volume":"22","author":"Peveler","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1111\/ppc.12050-BIB0027|ppc12050-cit-0027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: Mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Canadian Journal of Psychiatry"},{"issue":"6","key":"10.1111\/ppc.12050-BIB0028|ppc12050-cit-0028","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1592\/phco.26.6.748","article-title":"Atypical antipsychotics and pituitary tumors: A pharmacovigilance study","volume":"26","author":"Szarfman","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1111\/ppc.12050-BIB0029|ppc12050-cit-0029","first-page":"395","article-title":"Meta-analysis of comparative study of serum prolactin level between aripiprazole risperidone in the treatment of schizophrenia (in Chinese)","volume":"21","author":"Wang","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/ppc.12050-BIB0030|ppc12050-cit-0030","volume-title":"Guidelines for ATC Index with ddds","author":"WHO Collaborating Centre for Drug Statistic Methodology","year":"2002"},{"issue":"6","key":"10.1111\/ppc.12050-BIB0031|ppc12050-cit-0031","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1111\/ppc.12050-BIB0032|ppc12050-cit-0032","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JCP.0b013e3181ee832d","article-title":"Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia","volume":"30","author":"Yasui-Furukori","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/ppc.12050-BIB0033|ppc12050-cit-0033","first-page":"792","article-title":"Effects of olanzapine and haloperidol on serum prolactin and growth hormone in schizophrenia patients (in Chinese)","volume":"24","author":"Zhang","year":"2005","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"}],"container-title":["Perspectives in Psychiatric Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fppc.12050","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ppc.12050\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:16:29Z","timestamp":1671542189000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ppc.12050"}},"subtitle":["Frequency of Hyperprolactinemia"],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ppc.12050","relation":{},"ISSN":["0031-5990"],"issn-type":[{"value":"0031-5990","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,20]]}}}